Abstract:Background: Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the currently used techniques to identify biomarkers for cancers. The aim of this study is to explore the application of serum SELDI proteomic patterns to distinguish lung cancer patients from healthy individuals.Methods: A total of 208 serum samples, including 158 lung cancer patients and 50 healthy individuals, were randomly divided into a training set (including 11 sera from patients with stages I/II lung cancer, 63 from patients with stages III/IV lung cancer and 20 from healthy controls) and a blinded test set (including 43 sera from patients with stages I/II lung cancer, 41 from patients with stages III/IV lung cancer and 30 from healthy controls). All samples were analyzed by SELDI technology. The spectra were generated on weak cation exchange (WCX2) chips, and protein peaks clustering and classification analyses were made using Ciphergen Biomarker Wizard and Biomarker Pattern software, respectively. We additionally determined Cyfra21-1 and NSE in the 208 serum samples included in this study using an electrochemiluminescent immunoassay.Results: Five protein peaks at 11493, 6429, 8245, 5335 and 2538 Da were automatically chosen as a biomarker pattern in the training set. When the SELDI marker pattern was tested with the blinded test set, it yielded a sensitivity of 86.9%, a specificity of 80.0% and a positive predictive value of 92.4%. The sensitivities provided by Cyfra21-1 and NSE used individually or in combination were significantly lower than that of the SELDI marker pattern (P < 0.005 or 0.05, respectively). Based on the results of the test set, we found that the SELDI marker pattern showed a sensitivity of 91.4% in the detection of non-small cell lung cancers (NSCLC), which was significantly higher than that in the detection of small cell lung cancers (P < 0.05); The pattern also had a sensitivity of 79.1% in the detection of lung cancers in stages I/II.Conclusion: These results suggest that serum SELDI protein profiling can distinguish lung cancer patients, especially NSCLC patients, from normal subjects with relatively high sensitivity and specificity, and the SELDI- TOF- MS is a potential tool for the screening of lung cancer.

Application of Surface-enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry in Diagnosis of Cancer

[Application of Saliva Protein Fingerprints in the Diagnosis of Oral Squamous Cell Cancer by Surface Enhanced Laser Desorption Ionization Time of Flight Mass].

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Application of SELDI-TOF-MS in Laboratory Diagnosis

Application of Surface Enhanced Laser Desorption Ionization Proteinchip Technology in Diagnosis of Early Hepatocellular Carcinoma

Application of Laser Capture Microdissection and Surface-enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Biomarkers for Early Diagnosis of Lung Adenocarcinoma

Surface enhanced laser desorption ionization time-of-flight mass spectroscopy and breast cancer research

Screening of Serum Biomarkers in Hepatocellular Carcinoma by SELDI Technique: a Preliminary Study

Application of Serum Seldi Proteomic Patterns in Diagnosis of Lung Cancer

Application of SELDI-TOF-MS to Monitor Therapeutic Effect on Tumors

Application of Serum Surface-Enhanced Laser Desorption/ionization Proteomic Patterns in Distinguishing Lung Cancer Patients from Healthy People.

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

Advance in finding tumour marker with surface-enhanced laser desorption/ionization-time of flight mass spectrometry

SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.

Application of Seldi-Tof-Ms Coupled with an Artificial Neural Network Model to the Diagnosis of Pancreatic Cancer

The study of lung adenocarcinoma serum biomarkers selected by surface-enhanced laser desorption ionization spectrometry

Study on Serum Biomarkers Screening for Gastric Cancer Using SELDI-TOF-MS Technology

Application of SELDI-TOF MS Spectrometry in Serological Diagnosis for Esophageal Squamous Cell Carcinoma

[Application of SELDI-TOF MS Technology Analyzing Serum Protein Profiling for Distinguishing Laryngeal Carcinoma from Ordinary People].

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

Potential Role Of Proteomics In The Diagnosis Of Lymphoma: A Meta-Analysis